Ardent Health, Inc. ARDT
17.30 USD +1.40 (+8.81%)
At closeNov 6, 2026, 4:00 PM EST
17.30 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
15.58 Day range 17.68
7.71 52-week range 17.68
- YTD
- +95.92%
- 1 year
- +19.64%
Analyst view
Consensus: buy
Buy
Price target (mean) 12.79 -26.1% downside
Now 17.30
- Target (low)
- 11.00
- Target (mean)
- 12.79
- Target (high)
- 14.00
Ratings (0m) 13 7 buy · 5 hold · 1 sell
- Strong buy1
- Buy6
- Hold5
- Sell0
- Strong sell1
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.34333 | 0.33 – 0.36 | 0.3636 | -5.6% | 1.63B | +1.7% | 3 |
| Next quarter | 0.29333 | 0.25 – 0.36 | 0.3027 | -3.1% | 1.65B | +3.2% | 3 |
| Current year | 1.02 | 0.94 – 1.08 | 1.54 | -34.0% | 6.46B | +2.2% | 3 |
| Next year | 1.27 | 1.15 – 1.49 | 1.02 | +24.8% | 6.72B | +4.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Nov 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 23, 2026 | BMO Capital | Initiated | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 9, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | UBS | Maintained | Buy | Buy |
| Mar 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 6, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jan 20, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 18, 2025 | UBS | Maintained | Buy | Buy |
| Dec 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 24, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 17, 2025 | Keybanc | Downgrade | Overweight | Sector Weight |
| Nov 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 14, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 14, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Nov 14, 2025 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 13, 2025 | B of A Securities | Maintained | Underperform | Underperform |
| Oct 14, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Sep 10, 2025 | UBS | Initiated | — | Buy |
| Aug 11, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 7, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Jul 16, 2025 | B of A Securities | Downgrade | Neutral | Underperform |
| May 20, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
